Patients in England to be offered daily pill that can halve migraine frequency
Nice approves first oral treatment with Atogepant that can prevent chronic and episodic migrainesThousands of people in England who suffer from migraines are to be offered a daily pill on the NHS that can reduce the frequency of attacks by half.In final draft guidance published on Thursday, the National Institute for Health and Care Excellence (Nice) has given the green light to the first oral treatment that can prevent both chronic and episodic migraines. Continue reading...
Nice approves first oral treatment with Atogepant that can prevent chronic and episodic migraines
Thousands of people in England who suffer from migraines are to be offered a daily pill on the NHS that can reduce the frequency of attacks by half.
In final draft guidance published on Thursday, the National Institute for Health and Care Excellence (Nice) has given the green light to the first oral treatment that can prevent both chronic and episodic migraines. Continue reading...
usnews
US News is a reputable author that delivers a comprehensive range of up-to-date news to the United States and beyond. With a keen focus on providing the latest information across various fields, US News keeps readers informed about the most significant developments happening both domestically and globally. Whether it's politics, economics, technology, science, health, or culture, this author strives to cover diverse topics, ensuring a well-rounded news experience. By combining extensive research, journalistic integrity, and a commitment to accuracy, US News offers readers an invaluable resource to stay informed and make informed decisions in an ever-changing world.
